S&P 500   5,199.06
DOW   38,459.08
QQQ   445.37
Fastenal, CarMax fall; Alpine Immune Sciences, Arvinas rise, Thursday, 4/11/2024
Stock market today: Global markets mixed after Wall St rebound led by Big Tech
3 High-Yield Stocks In Rebound Mode: How High Can They Go?
NVIDIA Enters Correction: Worry or Opportunity?
How major US stock indexes fared Thursday, 4/11/2024
Dividend Aristocrat Fastenal Goes on Sale: Buy It While It’s Down
Blackstone’s $10 Billion Bet on Property Prices Going Up
S&P 500   5,199.06
DOW   38,459.08
QQQ   445.37
Fastenal, CarMax fall; Alpine Immune Sciences, Arvinas rise, Thursday, 4/11/2024
Stock market today: Global markets mixed after Wall St rebound led by Big Tech
3 High-Yield Stocks In Rebound Mode: How High Can They Go?
NVIDIA Enters Correction: Worry or Opportunity?
How major US stock indexes fared Thursday, 4/11/2024
Dividend Aristocrat Fastenal Goes on Sale: Buy It While It’s Down
Blackstone’s $10 Billion Bet on Property Prices Going Up
S&P 500   5,199.06
DOW   38,459.08
QQQ   445.37
Fastenal, CarMax fall; Alpine Immune Sciences, Arvinas rise, Thursday, 4/11/2024
Stock market today: Global markets mixed after Wall St rebound led by Big Tech
3 High-Yield Stocks In Rebound Mode: How High Can They Go?
NVIDIA Enters Correction: Worry or Opportunity?
How major US stock indexes fared Thursday, 4/11/2024
Dividend Aristocrat Fastenal Goes on Sale: Buy It While It’s Down
Blackstone’s $10 Billion Bet on Property Prices Going Up
S&P 500   5,199.06
DOW   38,459.08
QQQ   445.37
Fastenal, CarMax fall; Alpine Immune Sciences, Arvinas rise, Thursday, 4/11/2024
Stock market today: Global markets mixed after Wall St rebound led by Big Tech
3 High-Yield Stocks In Rebound Mode: How High Can They Go?
NVIDIA Enters Correction: Worry or Opportunity?
How major US stock indexes fared Thursday, 4/11/2024
Dividend Aristocrat Fastenal Goes on Sale: Buy It While It’s Down
Blackstone’s $10 Billion Bet on Property Prices Going Up

INVO Bioscience (INVO) Short Interest Ratio & Short Volume

$0.94
+0.15 (+18.99%)
(As of 04/11/2024 ET)

INVO Bioscience Short Interest Data

Current Short Volume
12,100 shares
Previous Short Volume
11,000 shares
Change Vs. Previous Month
+10.00%
Dollar Volume Sold Short
$13,673.00
Short Interest Ratio / Days to Cover
0.4
Last Record Date
March 31, 2024
Outstanding Shares
2,470,000 shares
Float Size
2,590,000 shares
Short Percent of Float
0.47%
Today's Trading Volume
16,951 shares
Average Trading Volume
22,102 shares
Today's Volume Vs. Average
77%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling INVO Bioscience ?

Sign up to receive the latest short interest report for INVO Bioscience and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

INVO Short Interest Over Time

INVO Days to Cover Over Time

INVO Percentage of Float Shorted Over Time

INVO Bioscience Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/31/202412,100 shares $13,673.00 +10.0%0.5%0.4 $1.13
3/15/202411,000 shares $11,330.00 -1.8%0.5%0.4 $1.03
2/29/202411,200 shares $12,880.00 -24.3%0.5%0.2 $1.15
2/15/202414,800 shares $12,551.88 -32.4%0.6%0.1 $0.85
1/31/202421,900 shares $21,900.00 +2.3%0.9%0 $1.00
1/15/202421,400 shares $22,470.00 -51.0%0.9%0 $1.05
12/31/202343,700 shares $58,995.00 -24.4%1.8%0 $1.35
12/15/202357,800 shares $71,094.00 -70.6%N/A0 $1.23
11/30/2023196,700 shares $367,829.00 -80.3%N/A0.1 $1.87
11/15/2023997,200 shares $1.84 million +245.1%N/A0.3 $1.85
10/31/2023289,000 shares $375,700.00 +397.4%N/A0.2 $1.30
10/15/202358,100 shares $39,827.55 -52.7%N/A0 $0.69
9/30/2023122,700 shares $96,957.54 +740.4%N/A0.6 $0.79
9/15/202314,600 shares $15,184.00 -13.6%N/A0.1 $1.04
8/31/202316,900 shares $25,519.00 -86.7%N/A0.1 $1.51
8/15/2023127,400 shares $181,545.00 +182.5%N/A0.5 $1.43
7/31/202345,100 shares $223,696.00 -84.5%N/A0.2 $4.96
7/15/2023290,600 shares $51,145.60 -38.8%N/A0.2 $0.18
6/30/2023474,800 shares $95,054.96 +363.2%3.2%0.4 $0.20
6/15/2023102,500 shares $17,404.50 +94.5%0.8%0.1 $0.17
5/31/202352,700 shares $13,417.42 -28.6%0.4%0.1 $0.25
5/15/202373,800 shares $26,095.68 No Change0.6%0.4 $0.35
10/31/202259,200 shares $68,080.00 -17.2%N/A2.4 $1.15
10/15/202271,500 shares $88,660.00 +3.6%N/A2.8 $1.24
9/30/202269,000 shares $73,140.00 +102.9%N/A2.6 $1.06
9/15/202234,000 shares $49,640.00 +38.8%N/A1 $1.46
8/31/202224,500 shares $23,716.00 -63.6%N/A0.8 $0.97
8/15/202267,300 shares $76,049.00 +3.9%N/A1.5 $1.13
7/31/202264,800 shares $64,152.00 +19.8%N/A1.4 $0.99
7/15/202254,100 shares $51,936.00 -30.7%N/A1.1 $0.96
6/30/202278,100 shares $49,976.19 +65.5%N/A1.5 $0.64
6/15/202247,200 shares $41,819.20 -42.1%N/A0.9 $0.89
5/31/202281,500 shares $79,829.25 +13.5%N/A1.5 $0.98
5/15/202271,800 shares $101,956.00 +22.5%N/A1.9 $1.42
4/30/202258,600 shares $88,486.00 -34.0%N/A1.7 $1.51
4/15/202288,800 shares $166,944.00 -1.0%N/A2.1 $1.88
3/31/202289,700 shares $236,808.00 +27.1%N/A2.2 $2.64
3/15/202270,600 shares $154,614.00 +2.3%N/A1.6 $2.19
2/28/202269,000 shares $207,690.00 +63.5%N/A1.5 $3.01
2/15/202242,200 shares $127,022.00 -44.2%N/A1 $3.01
Weiss issues 'Buy' on AI sleeper stock (Ad)

Based on our Weiss Ratings, we’ve issued a “Buy” on an under-the-radar AI stock. And we share the details at our Artificial Intelligence Town Hall ….

To watch our Town Hall now, click here.

INVO Short Interest - Frequently Asked Questions

What is INVO Bioscience's current short interest?

Short interest is the volume of INVO Bioscience shares that have been sold short but have not yet been covered or closed out. As of March 31st, traders have sold 12,100 shares of INVO short. 0.47% of INVO Bioscience's shares are currently sold short. Learn More on INVO Bioscience's current short interest.

Which institutional investors are shorting INVO Bioscience?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of INVO Bioscience: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for INVO Bioscience?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.47% of INVO Bioscience's floating shares are currently sold short.

Is INVO Bioscience's short interest increasing or decreasing?

INVO Bioscience saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 12,100 shares, an increase of 10.0% from the previous total of 11,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is INVO Bioscience's float size?

INVO Bioscience currently has issued a total of 2,470,000 shares. Some of INVO Bioscience's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. INVO Bioscience currently has a public float of 2,590,000 shares.

How does INVO Bioscience's short interest compare to its competitors?

0.47% of INVO Bioscience's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to INVO Bioscience: ReShape Lifesciences Inc. (3.50%), Dynatronics Co. (0.57%), Motus GI Holdings, Inc. (0.46%), Nemaura Medical Inc. (0.34%), Bluejay Diagnostics, Inc. (0.65%), Quoin Pharmaceuticals, Ltd. (0.31%), Tenon Medical, Inc. (3.32%), Sintx Technologies, Inc. (5.38%), Venus Concept Inc. (0.72%), Aethlon Medical, Inc. (0.74%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks.

What does it mean to sell short INVO Bioscience stock?

Short selling INVO is an investing strategy that aims to generate trading profit from INVO Bioscience as its price is falling. INVO shares are trading up $0.15 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against INVO Bioscience?

A short squeeze for INVO Bioscience occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of INVO, which in turn drives the price of the stock up even further.

How often is INVO Bioscience's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including INVO, twice per month. The most recent reporting period available is March, 31 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:INVO) was last updated on 4/12/2024 by MarketBeat.com Staff

From Our Partners